Cell Sourcing
& Apheresis
Optimized Process Development
for Cell & Gene Therapies
Service
Description
Why
Choose us?
National Cord Blood Program
Excellence in Clinical Apheresis
iPSCs as Starting Material
Proud Partner of NMDPsm
Initiating collections for the NMDP (formerly known as the National Marrow Donor Program) in 2005, Comprehensive Cell Solutions has been a preferred partner and NMDP Collection Center since 2022. Since beginning NMDP collection services at CCS, our nurses have collected over 1,700 stem cell and mononuclear cell (i.e., T cell) apheresis products for NMDP transplant patients in the US and internationally.
Commitment to Quality
All products are collected according to NMDP and CCS rigorous quality standards, with the CCS team achieving 98.47% product quality as defined by percentage of collected stem cell products (minimum of CD34+ 4.5×10^6/kg) through final product counts.
Patient & Donor Focus
The CCS apheresis team also regularly exceeds donor satisfaction scores, achieving 4.87 on a scale of 1-5, with criteria such as the team’s ability to provide exceptional medical care, exhibit an outstanding bedside manner, discuss and address any concerns, and demonstrate appreciation for the donation.
What Donors Are Saying:
“Willy was my nurse and was so kind and supportive. He explained things well, he was interactive and funny but allowed me to rest and watch TV without interruptions. He was patient and understanding when I needed to use the restroom.”
Method Development
We design and optimize analytical methods to ensure accurate testing of cell identity, potency, purity, and sterility for your therapy.
Stability Studies
We design stability-indicating assays to assess long-term storage and shelf life, ensuring reliable quality control for cell therapy products.
Process Monitoring & In-Process Testing
We conduct in-process testing to ensure process control, consistency, and product quality, using metrics like cell count, viability, phenotype analysis, and advanced proteomic/genomic monitoring.
Release Testing
We develop assays to confirm that your cell therapy product meets all specifications and critical quality attributes for clinical use.
Characterization of Cell-Based Products
We provide flow cytometry, ELISA, PCR, and other assays to verify cell identity, purity, and potency, ensuring regulatory and clinical compliance.
Documentation
We provide comprehensive, traceable documentation to support regulatory filings and ensure a seamless submission process.